repaglinide has been researched along with Body Weight in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chehab, MR; Gumieniczek, A; Komsta, L | 1 |
| Abrams, Z; Lieberman, N; Shapiro, MS | 1 |
| Gumieniczek, A | 2 |
| Frandsen, M; Lund, SS; Parving, HH; Pedersen, O; Schalkwijk, CG; Smidt, UM; Stehouwer, CD; Tarnow, L; Vaag, A | 1 |
| Frandsen, M; Gram, J; Lund, SS; Parving, HH; Pedersen, O; Schalkwijk, CG; Smidt, UM; Stehouwer, CD; Tarnow, L; Teerlink, T; Vaag, AA; Winther, K | 1 |
| Nattrass, M | 1 |
| Dedov, I; Frandsen, KB; Gomis, R; Moses, RG; Schlienger, JL | 1 |
| Kalbag, JB; McLeod, JF; Nedelman, JR; Walter, YH | 1 |
5 trial(s) available for repaglinide and Body Weight
| Article | Year |
|---|---|
Clinical experience with repaglinide in patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Body Weight; Carbamates; Diabetes Mellitus, Type 2; Diet; Feeding Behavior; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Piperidines; Stereoisomerism; Treatment Outcome | 2005 |
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.
Topics: Adiponectin; Biomarkers; Blood Glucose; Body Weight; C-Peptide; C-Reactive Protein; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Patient Compliance; Piperidines; Prospective Studies; Waist-Hip Ratio | 2007 |
Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Body Weight; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Piperidines; Risk Factors; Treatment Outcome; Vasculitis | 2008 |
Flexible meal-related dosing with repaglinide facilitates glycemic control in therapy-naive type 2 diabetes.
Topics: Aged; Blood Glucose; Body Weight; Carbamates; Diabetes Mellitus, Type 2; Diet; Double-Blind Method; Fasting; Female; Food; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Piperidines; Placebos | 2001 |
Mealtime glucose regulation with nateglinide in healthy volunteers: comparison with repaglinide and placebo.
Topics: Adolescent; Adult; Blood Glucose; Body Mass Index; Body Weight; Carbamates; Cross-Over Studies; Cyclohexanes; Female; Food; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Kinetics; Male; Middle Aged; Nateglinide; Phenylalanine; Piperidines; Placebos; Time Factors | 2001 |
4 other study(ies) available for repaglinide and Body Weight
| Article | Year |
|---|---|
Effects of two oral antidiabetics, pioglitazone and repaglinide, on aconitase inactivation, inflammation and oxidative/nitrosative stress in tissues under alloxan-induced hyperglycemia.
Topics: Aconitate Hydratase; Administration, Oral; Alloxan; Animals; Blood Glucose; Body Weight; Carbamates; Enzyme Activation; Hyperglycemia; Hypoglycemic Agents; Inflammation; Insulin; Lipid Peroxidation; Male; Oxidative Stress; Pioglitazone; Piperidines; Rabbits; Reactive Nitrogen Species; Thiazolidinediones | 2011 |
Effects of repaglinide on oxidative stress in tissues of diabetic rabbits.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Carbamates; Diabetes Mellitus, Experimental; Glutathione Peroxidase; Glutathione Reductase; Hypoglycemic Agents; Kidney; Liver; Male; Oxidative Stress; Piperidines; Rabbits; Time Factors | 2005 |
Oxidative stress in kidney and liver of alloxan-induced diabetic rabbits: effect of repaglinide.
Topics: Animals; Blood Glucose; Body Weight; Carbamates; Catalase; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Oxidative Stress; Piperidines; Rabbits; Superoxide Dismutase | 2005 |
Repaglinide: a novel oral antidiabetic agent.
Topics: Administration, Oral; Blood Glucose; Body Weight; Carbamates; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Hypoglycemic Agents; Piperidines; Sulfonylurea Compounds | 2000 |